It is also possible that Foxp1 depletion may improve lymphocyte migration into the tumor microenvironment, as is the case in breast cancer where FOXP1 has recently been identified as a negative regulator of tumor infiltrating lymphocyte migration (43). The gene discussed is FOXP1; the disease is breast carcinoma.